Mechanism of Inhibition of Neointimal Formation by the Angiotensin-Converting Enzyme Inhibitor Cilazapril
- 1 November 1995
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 15 (11), 1945-1950
- https://doi.org/10.1161/01.atv.15.11.1945
Abstract
Abstract We investigated the mechanism of inhibition of neointima formation by the angiotensin-converting enzyme inhibitor cilazapril in a rat model of balloon-catheter injury in the carotid artery. We looked for the effects of cilazapril on all phases of the response to injury, ie, on proliferation of smooth muscle cells (SMCs) in the media, their migration, their proliferation in the neointima, and their deposition of extracellular matrix in the neointima. Although treatment was discontinued after 2 weeks, the inhibitory effect of cilazapril on neointimal formation was evident even 52 weeks after injury. The amount of extracellular matrix deposited in the intima during cilazapril treatment was decreased by 20% 2 weeks after injury, but no effect was seen if tissues were analyzed at 4 or 52 weeks. [ 3 H]Thymidine-labeled cells (pulse labeling as well as 14-day continuous labeling) showed a decrease in SMC labeling in the tunica media by 50%, but no inhibition in the labeling indices was seen in the neointima. The fraction of unlabeled neointimal cells in the cilazapril-treated rats as judged from continuous labeling experiments was inhibited by 86%. Taken together, these data suggest an antiproliferative effect on medial SMCs and an inhibition of SMC migration into the intima by cilazapril. Since intimal extracellular matrix deposition was only delayed, the decrease in medial SMC proliferation and subsequent migration seems to be the main reason for the reduction of neointima formation.Keywords
This publication has 18 references indexed in Scilit:
- Fibroblast growth factor stimulates angiotensin converting enzyme expression in vascular smooth muscle cells. Possible mediator of the response to vascular injury.JCI Insight, 1995
- Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury modelAmerican Heart Journal, 1993
- Microinjection of α-Calcitonin Gene-Related Peptide into the Hypothalamus Activates Sympathetic Outflow in RatsThe Japanese Journal of Pharmacology, 1993
- Role of angiotensin subtype 2 receptor in neointima formation after vascular injury.Hypertension, 1992
- Kinins mediate the antiproliferative effect of ramipril in rat carotid arteryBiochemical and Biophysical Research Communications, 1992
- Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteriesLife Sciences, 1991
- Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon.Hypertension, 1991
- Role of angiotensin II in injury-induced neointima formation in rats.Hypertension, 1991
- Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs.Hypertension, 1991
- Cilazapril inhibits wall thickening of vein bypass graft in the rat.Hypertension, 1991